top of page

ThermoFisher-Qiagen deal off

- Thermo Fisher has a revenue of $24B

- Qiagen is a molecular diagnostics company

- originally $11,5B deal

- couldn't find the shareholder support - only 47 % out of 66 % needed shares were tendered

Source: Medtechdive

Read more:

#medicaldevices #mergersandacquisitions #moleculardiagnostics

6 views0 comments

Recent Posts

See All

Dear all, here are the great sources that caught our eye in the last weeks regarding the medical device industry outlook as of 2021. Including: - EY report, 2021 - McKinsey report, 2021 - MedTech Dive

bottom of page